GBP2 and sporadic Creutzfeldt-Jakob disease: Additionally, data from human patients with sporadic Creutzfeldt-Jakob Disease (sCJD) show that A1 astrocyte markers, such as GBP2, stratify to molecular subtypes in sCJD brains, which may account for the divergence of A1 astrocytic markers among molecular subtypes in these patients32.